Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.verified

1167.HK

Price:

$8.86

Market Cap:

$6.31B

Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-634...[Read more]

Industry

Biotechnology

IPO Date

2020-12-21

Stock Exchange

HKSE

Ticker

1167.HK

The Enterprise Value as of December 2025 (TTM) for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) is 5.46B

According to Jacobio Pharmaceuticals Group Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.46B. This represents a change of 456.73% compared to the average of 981.26M of the last 4 quarters.

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Historical Enterprise Value (quarterly & annually)

How has 1167.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Jacobio Pharmaceuticals Group Co., Ltd. over the last ten years is 5.31B. The current 5.46B Enterprise Value has changed 10.19% with respect to the historical average. Over the past ten years (40 quarters), 1167.HK's Enterprise Value was at its highest in in the June 2021 quarter at 11.89B. The Enterprise Value was at its lowest in in the December 2024 quarter at -100458628.21.

Quarterly (TTM)
Annual

Average

5.31B

Median

7.30B

Minimum

-98278536.34

Maximum

9.49B

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jacobio Pharmaceuticals Group Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.08%

Maximum Annual Enterprise Value = 9.49B

Minimum Annual Increase = -106.14%

Minimum Annual Enterprise Value = -98278536.34

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-98278536.34-106.14%
20231.60B-31.44%
20222.34B-68.01%
20217.30B-0.33%
20207.33B-22.79%
20199.49B3.08%

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Average Enterprise Value

How has 1167.HK Enterprise Value performed in the past?

The current Enterprise Value of Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.28B

5-year avg

3.69B

10-year avg

5.31B

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Enterprise Value vs. Peers

How is 1167.HK’s Enterprise Value compared to its peers?

Jacobio Pharmaceuticals Group Co., Ltd.’s Enterprise Value is greater than Qyuns Therapeutics Co., Ltd. (4.02B), greater than Viva Biotech Holdings (3.94B), greater than TYK Medicines, Inc (4.19B), greater than AIM Vaccine Co., Ltd. (5.26B), greater than Jiangxi Rimag Group Co., Ltd. (3.28B), less than Ocumension Therapeutics (5.48B), less than Medtide Inc. (0), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1.96B), greater than Tong Ren Tang Technologies Co. Ltd. (2.84B), greater than Yidu Tech Inc. (3.67B),

Build a custom stock screener for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jacobio Pharmaceuticals Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jacobio Pharmaceuticals Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Jacobio Pharmaceuticals Group Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?

What is the 3-year average Enterprise Value for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?

What is the 5-year average Enterprise Value for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?

How does the current Enterprise Value for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) compare to its historical average?